Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
2003
220
LTM Revenue $45.2M
LTM EBITDA $3.9M
$98.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Medical Data Vision has a last 12-month revenue (LTM) of $45.2M and a last 12-month EBITDA of $3.9M.
In the most recent fiscal year, Medical Data Vision achieved revenue of $40.5M and an EBITDA of $0.9M.
Medical Data Vision expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Medical Data Vision valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $45.2M | XXX | $40.5M | XXX | XXX | XXX |
Gross Profit | $33.3M | XXX | $29.7M | XXX | XXX | XXX |
Gross Margin | 74% | XXX | 73% | XXX | XXX | XXX |
EBITDA | $3.9M | XXX | $0.9M | XXX | XXX | XXX |
EBITDA Margin | 9% | XXX | 2% | XXX | XXX | XXX |
EBIT | $3.1M | XXX | $26K | XXX | XXX | XXX |
EBIT Margin | 7% | XXX | 0% | XXX | XXX | XXX |
Net Profit | -$1.3M | XXX | -$5.4M | XXX | XXX | XXX |
Net Margin | -3% | XXX | -13% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Medical Data Vision's stock price is JPY 414 (or $3).
Medical Data Vision has current market cap of JPY 15.7B (or $108M), and EV of JPY 14.3B (or $98.3M).
See Medical Data Vision trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$98.3M | $108M | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Medical Data Vision has market cap of $108M and EV of $98.3M.
Medical Data Vision's trades at 2.4x EV/Revenue multiple, and 109.0x EV/EBITDA.
Equity research analysts estimate Medical Data Vision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medical Data Vision has a P/E ratio of -85.3x.
See valuation multiples for Medical Data Vision and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $108M | XXX | $108M | XXX | XXX | XXX |
EV (current) | $98.3M | XXX | $98.3M | XXX | XXX | XXX |
EV/Revenue | 2.2x | XXX | 2.4x | XXX | XXX | XXX |
EV/EBITDA | 25.3x | XXX | 109.0x | XXX | XXX | XXX |
EV/EBIT | 31.8x | XXX | 3804.9x | XXX | XXX | XXX |
EV/Gross Profit | 3.0x | XXX | n/a | XXX | XXX | XXX |
P/E | -85.3x | XXX | -19.8x | XXX | XXX | XXX |
EV/FCF | -20.5x | XXX | -13.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedical Data Vision's last 12 month revenue growth is 21%
Medical Data Vision's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Medical Data Vision's rule of 40 is 50% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medical Data Vision's rule of X is 60% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medical Data Vision and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 21% | XXX | 20% | XXX | XXX | XXX |
EBITDA Margin | 9% | XXX | 2% | XXX | XXX | XXX |
EBITDA Growth | 135% | XXX | -20% | XXX | XXX | XXX |
Rule of 40 | 50% | XXX | 23% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 60% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 73% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medical Data Vision acquired XXX companies to date.
Last acquisition by Medical Data Vision was XXXXXXXX, XXXXX XXXXX XXXXXX . Medical Data Vision acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Medical Data Vision founded? | Medical Data Vision was founded in 2003. |
Where is Medical Data Vision headquartered? | Medical Data Vision is headquartered in Japan. |
How many employees does Medical Data Vision have? | As of today, Medical Data Vision has 220 employees. |
Is Medical Data Vision publicy listed? | Yes, Medical Data Vision is a public company listed on TKS. |
What is the stock symbol of Medical Data Vision? | Medical Data Vision trades under 3902 ticker. |
When did Medical Data Vision go public? | Medical Data Vision went public in 2014. |
Who are competitors of Medical Data Vision? | Similar companies to Medical Data Vision include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Medical Data Vision? | Medical Data Vision's current market cap is $108M |
What is the current revenue of Medical Data Vision? | Medical Data Vision's last 12 months revenue is $45.2M. |
What is the current revenue growth of Medical Data Vision? | Medical Data Vision revenue growth (NTM/LTM) is 21%. |
What is the current EV/Revenue multiple of Medical Data Vision? | Current revenue multiple of Medical Data Vision is 2.2x. |
Is Medical Data Vision profitable? | Yes, Medical Data Vision is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Medical Data Vision? | Medical Data Vision's last 12 months EBITDA is $3.9M. |
What is Medical Data Vision's EBITDA margin? | Medical Data Vision's last 12 months EBITDA margin is 9%. |
What is the current EV/EBITDA multiple of Medical Data Vision? | Current EBITDA multiple of Medical Data Vision is 25.3x. |
What is the current FCF of Medical Data Vision? | Medical Data Vision's last 12 months FCF is -$4.8M. |
What is Medical Data Vision's FCF margin? | Medical Data Vision's last 12 months FCF margin is -11%. |
What is the current EV/FCF multiple of Medical Data Vision? | Current FCF multiple of Medical Data Vision is -20.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.